Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paul B Rizzoli

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Harvard Health Letter|March 10, 2012
Talking about migrainePaul B Rizzoli
Neuropsychiatric Disease and Treatment|April 15, 2014
Emerging therapeutic options for acute migraine: focus on the potential of lasmiditanPaul B Rizzoli
Continuum (Minneapolis, Minn.)|August 8, 2012
Acute and preventive treatment of migrainePaul B Rizzoli
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|June 16, 2018
What the pharmacological management of migraine can tell us about the future of migraine patient carePaul B Rizzoli
The Medical Clinics of North America|February 2, 2019
Nonmigraine Headache and Facial PainAngeliki Vgontzas, Paul B Rizzoli
Headache|June 21, 2021
Adaptation of the management of chronic migraine patients with medication overuse to the suspension of treatment protocols during the COVID-19 pandemic: Lessons from a tertiary headache center in Milan-6-month resultsPaul B Rizzoli, Licia Grazzi
Neurosurgery|March 11, 2015
Correspondence: Obituary, Hugo V. Rizzoli, MD, FACSEdward R Laws, Paul B Rizzoli
Headache|February 26, 2019
International Clinical Collaboration in Headache Medicine: The International Visiting Scholars ProgramPaul B Rizzoli, Giuseppe Lauria Pinter, Licia Grazzi
Neurology|August 20, 2017
Medication overuse headache: An entrenched idea in need of scrutinyAnn I Scher, Paul B Rizzoli, Elizabeth W Loder
Headache|January 11, 2020
Intranasal 3% Tetracaine Plus 0.05% Oxymetazoline in the Management of Status MigrainosusMelissa Darsey, Theodore Kyros, Victor Wang, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Harvard Health Letter|March 10, 2012
Talking about migrainePaul B Rizzoli
Neuropsychiatric Disease and Treatment|April 15, 2014
Emerging therapeutic options for acute migraine: focus on the potential of lasmiditanPaul B Rizzoli
Continuum (Minneapolis, Minn.)|August 8, 2012
Acute and preventive treatment of migrainePaul B Rizzoli
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|June 16, 2018
What the pharmacological management of migraine can tell us about the future of migraine patient carePaul B Rizzoli
The Medical Clinics of North America|February 2, 2019
Nonmigraine Headache and Facial PainAngeliki Vgontzas, Paul B Rizzoli
Headache|June 21, 2021
Adaptation of the management of chronic migraine patients with medication overuse to the suspension of treatment protocols during the COVID-19 pandemic: Lessons from a tertiary headache center in Milan-6-month resultsPaul B Rizzoli, Licia Grazzi
Neurosurgery|March 11, 2015
Correspondence: Obituary, Hugo V. Rizzoli, MD, FACSEdward R Laws, Paul B Rizzoli
Headache|February 26, 2019
International Clinical Collaboration in Headache Medicine: The International Visiting Scholars ProgramPaul B Rizzoli, Giuseppe Lauria Pinter, Licia Grazzi
Neurology|August 20, 2017
Medication overuse headache: An entrenched idea in need of scrutinyAnn I Scher, Paul B Rizzoli, Elizabeth W Loder
Headache|January 11, 2020
Intranasal 3% Tetracaine Plus 0.05% Oxymetazoline in the Management of Status MigrainosusMelissa Darsey, Theodore Kyros, Victor Wang, et al.
Pageof 2